Reports
Sale
Global Small Molecule API Market Size, Report: By Type: Synthetic/Chemical API, Biological API; By Therapeutic Type: Autoimmune Diseases, Oncology, Metabolic Diseases, Ophthalmology, Others; By Manufacturing Method: In-House, Contract; By Applications: Clinical, Commercial; Regional Analysis; Patent Analysis; Supplier Landscape; 2024-2032
Global Small Molecule API Market Outlook
The global small molecule API market size was valued at USD 195.87 billion in 2023, driven by the rising demand for innovative therapeutic drugs for chronic and rare diseases across the globe. The market size is anticipated to grow at a CAGR of 6.8% during the forecast period of 2024-2032 to achieve a value of USD 354.09 billion by 2032.
Small Molecule API: Introduction
Small molecule API are active pharmaceutical ingredients with low molecular weight compound and size of nearly 1nm. These small molecule APIs are useful in controlling the biological processes. They can be used as research tools to investigate the biological functions and in the development of new therapeutic drugs. The term small molecule is usually restricted in pharmacology for molecules that bind specific biological macromolecules and act as a stimulator, manipulating the activity or function of the target.
Global Small Molecule API Market Analysis
The global market for small molecule API is influenced by several factors such as increased research and development activities within the pharmaceutical sector. Pharmaceutical companies across the world are increasing their research towards the use and exploring the full potential of small molecule API in a range of rare diseases and disorders as well, which is contributing to the market growth. The increasing prevalence of chronic disease and rising demand for generic medicines are also major factors contributing to the market growth of small molecule API. Increased technological advancements in manufacturing and availability of cost-effective treatment options are also influencing the global small molecule API market growth.
The utilization of small molecule API in the development of targeted treatment of rare diseases such as cancer and other autoimmune diseases, is a major factor driving the market growth. Such involvement can result in new market opportunities for small molecule API companies. Additionally, the rising diseases such as diabetes, cardiovascular disease, and cancer are also driving the high demand for pharmaceutical drugs globally, which also includes precision or targeted medicines.
The heavy investments made by the key players in advanced technology and infrastructure for develop high-potency APIs (HPAPIs) is expected to aid the global small molecule API market share. The advancements in manufacturing techniques and technologies have enabled large-scale production of high-quality APIs. These innovations have improved manufacturing efficiency and reduced costs which has made pharmaceutical drugs affordable and accessible for patients, further boosting the high demand in market. The rising approvals of new drugs in the market, backed by extensive research and clinical trials are further propelling the market expansion.
Global Small Molecule API Market Segmentations
Market Breakup by Type
- Synthetic/Chemical API
- Biological API
Market Breakup by Therapeutic Type
- Autoimmune Diseases
- Oncology
- Metabolic Diseases
- Ophthalmology
- Cardiovascular Diseases
- Infectious Diseases
- Neurology
- Respiratory Disorders
- Dermatology
- Urology
- Others
Market Breakup by Manufacturing Method
- In-House
- Contract
Market Breakup by Applications
- Clinical
- Commercial
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Small Molecule API Market Overview
The small molecule API market has been witnessing a significant growth due to the increasing demand for adequate treatment of population worldwide. The small molecule API market is majorly driven by the utilization in three therapeutic areas such as oncology, immunology, and antidiabetics. The growing demand of highly potent active pharmaceutical ingredients (HPAPIs) is directly associated with the increasing prevalence of rare diseases such as cancer. HPAPIs are special ingredient used in oncology and treatment of several other diseases such as diabetes and autoimmune diseases. The HPAPI market is growing at a much faster rate comparatively due to the high potential. With increasing developments, the ability of HPAPIs to target the cause of disease has also improved which is further escalating the global small molecule API market demand.
Geographically, North America is leading the market growth and is expected to lead throughout the forecast period. The increasing prevalence of chronic diseases in the region is driving the market growth. The increased government initiatives towards the development of new, innovative, and improved drugs are further boosting the regional growth of the market.
Small Molecule API Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Albemarle Corporation
- Allergan
- Aurobindo Pharma
- Cambrex Corporation
- Dr. Reddy’s Laboratories Ltd.
- GSk plc.
- Lonza
- Merck KGaA
- Novartis AG
- Pfizer Inc.
- Siegfried Holding AG
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Johnson Matthey
- Gilead Sciences, Inc.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Therapeutic Type |
|
| Breakup by Manufacturing Method |
|
| Breakup by Applications |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Small Molecule API Market Overview
3.1 Global Small Molecule API Market Historical Value (2017-2023)
3.2 Global Small Molecule API Market Forecast Value (2024-2032)
4 Global Small Molecule API Market Landscape
4.1 Global Small Molecule API Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Small Molecule API Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Therapeutic Type
4.2.3 Analysis by Applications
5 Global Small Molecule API Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Small Molecule API Market Segmentation
6.1 Global Small Molecule API Market by Type
6.1.1 Market Overview
6.1.2 Synthetic/Chemical API
6.1.3 Biological API
6.2 Global Small Molecule API Market by Therapeutic Type
6.2.1 Market Overview
6.2.2 Autoimmune Diseases
6.2.3 Oncology
6.2.4 Metabolic Diseases
6.2.5 Ophthalmology
6.2.6 Cardiovascular Diseases
6.2.7 Infectious Diseases
6.2.8 Neurology
6.2.9 Respiratory Disorders
6.2.10 Dermatology
6.2.11 Urology
6.2.12 Others
6.3 Global Small Molecule API Market by Manufacturing Method
6.3.1 Market Overview
6.3.2 In-House
6.3.3 Contract
6.4 Global Small Molecule API Market by Applications
6.4.1 Market Overview
6.4.2 Clinical
6.4.3 Commercial
6.5 Global Small Molecule API Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Small Molecule API Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Small Molecule API Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Small Molecule API Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Small Molecule API Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Small Molecule API Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Albemarle Corporation
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisition
17.1.5 Certifications
17.2 Allergan
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisition
17.2.5 Certifications
17.3 Aurobindo Pharma
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisition
17.3.5 Certifications
17.4 Cambrex Corporation
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisition
17.4.5 Certifications
17.5 Dr. Reddy’s Laboratories Ltd.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisition
17.5.5 Certifications
17.6 GSk plc.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisition
17.6.5 Certifications
17.7 Lonza
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisition
17.7.5 Certifications
17.8 Merck KGaA
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisition
17.8.5 Certifications
17.9 Novartis AG
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisition
17.9.5 Certifications
17.10 Pfizer Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisition
17.10.5 Certifications
17.11 Siegfried Holding AG
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisition
17.11.5 Certifications
17.12 Sun Pharmaceutical Industries Ltd.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisition
17.12.5 Certifications
17.13 Teva Pharmaceutical Industries Ltd.
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisition
17.13.5 Certifications
17.14 Johnson Matthey
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisition
17.14.5 Certifications
17.15 Gilead Sciences, Inc.
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisition
17.15.5 Certifications
18 Global Small Molecule API Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of about USD 195.87 billion in 2023, driven by the increasing prevalence of cancer.
The market is anticipated to grow at a CAGR of 6.8% during the forecast period of 2024-2032, likely to reach a market value of USD 354.09 billion by 2032.
The increased demand for new and improved therapeutic drugs across the globe is a major factor driving the demand for the market.
The increasing FDA approvals for new drugs and the utilization of HPAPIs in the development of precision drugs is key trend influencing the market growth.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.
Synthetic/chemical API and biological API are two types of small molecule APIs.
They can be used in autoimmune diseases, oncology, metabolic diseases, ophthalmology, cardiovascular diseases, infectious diseases, neurology, respiratory disorders, dermatology, and urology, among others.
They could be manufactured in-house or on contractual basis.
They find wide applications in clinical and commercial sector.
Key players involved in the market are Albemarle Corporation, Allergan, Aurobindo Pharma, Cambrex Corporation, Dr. Reddy’s Laboratories Ltd., GSk plc., Lonza, Merck KGaA, Novartis AG, Pfizer Inc., Siegfried Holding AG, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Gilead Sciences, Inc., and Johnson Matthey.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER